97 related articles for article (PubMed ID: 29741770)
1. EOMES/TBET and soluble CTLA4/full length CTLA4 expression ratios impact on the therapeutic response in patients with classical Hodgkin lymphoma.
Vera-Lozada G; Barros MHM; Alves P; Segges P; Land MGP; Hassan R
Br J Haematol; 2019 Mar; 184(6):1061-1064. PubMed ID: 29741770
[No Abstract] [Full Text] [Related]
2. Eomesodermin(lo) CTLA4(hi) Alloreactive CD8+ Memory T Cells Are Associated With Prolonged Renal Transplant Survival Induced by Regulatory Dendritic Cell Infusion in CTLA4 Immunoglobulin-Treated Nonhuman Primates.
Ezzelarab MB; Lu L; Guo H; Zahorchak AF; Shufesky WF; Cooper DK; Morelli AE; Thomson AW
Transplantation; 2016 Jan; 100(1):91-102. PubMed ID: 26680373
[TBL] [Abstract][Full Text] [Related]
3. CTLA4 haploinsufficiency as a predisposition to classical Hodgkin lymphoma.
Mahat U; Terzioglu MK; Buhtoiarov I
Pediatr Hematol Oncol; 2020 Mar; 37(2):176-183. PubMed ID: 31971458
[TBL] [Abstract][Full Text] [Related]
4. Tumor microenvironment composition in pediatric classical Hodgkin lymphoma is modulated by age and Epstein-Barr virus infection.
Barros MH; Vera-Lozada G; Soares FA; Niedobitek G; Hassan R
Int J Cancer; 2012 Sep; 131(5):1142-52. PubMed ID: 22025264
[TBL] [Abstract][Full Text] [Related]
5. Pathway-focused gene expression profiles and immunohistochemistry detection identify contrasting association of caspase 3 (CASP3) expression with prognosis in pediatric classical Hodgkin lymphoma.
Vera-Lozada G; Segges P; Stefanoff CG; Barros MHM; Niedobitek G; Hassan R
Hematol Oncol; 2018 Oct; 36(4):663-670. PubMed ID: 29901224
[TBL] [Abstract][Full Text] [Related]
6. CD20 expression by Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma is related to reduced overall survival in young adult patients.
Aldred V; Vassallo J; Froes M Campos AH; Augusto Soares F
Leuk Lymphoma; 2008 Nov; 49(11):2198-202. PubMed ID: 18661400
[No Abstract] [Full Text] [Related]
7. CTLA4 Promotes Tyk2-STAT3-Dependent B-cell Oncogenicity.
Herrmann A; Lahtz C; Nagao T; Song JY; Chan WC; Lee H; Yue C; Look T; Mülfarth R; Li W; Jenkins K; Williams J; Budde LE; Forman S; Kwak L; Blankenstein T; Yu H
Cancer Res; 2017 Sep; 77(18):5118-5128. PubMed ID: 28716895
[TBL] [Abstract][Full Text] [Related]
8. In vitro Treg expansion favors the full-length splicing isoform of CTLA4.
Kaartinen T; Harjunpää H; Partanen J; Tiittanen M
Immunotherapy; 2016 May; 8(5):541-53. PubMed ID: 27140408
[TBL] [Abstract][Full Text] [Related]
9. Checkpoint Inhibition in Hodgkin Lymphoma - a Review.
Bröckelmann PJ; Engert A
Oncol Res Treat; 2017; 40(11):654-660. PubMed ID: 29065424
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signaling 1 gene mutation status as a prognostic biomarker in classical Hodgkin lymphoma.
Lennerz JK; Hoffmann K; Bubolz AM; Lessel D; Welke C; Rüther N; Viardot A; Möller P
Oncotarget; 2015 Oct; 6(30):29097-110. PubMed ID: 26336985
[TBL] [Abstract][Full Text] [Related]
11. Classical Hodgkin lymphoma, lymphocyte depleted type: clinicopathological analysis and prognostic comparison with other types of classical Hodgkin lymphoma.
Karube K; Niino D; Kimura Y; Ohshima K
Pathol Res Pract; 2013 Apr; 209(4):201-7. PubMed ID: 23478005
[TBL] [Abstract][Full Text] [Related]
12. Complete Local and Abscopal Responses from a Combination of Radiation and Nivolumab in Refractory Hodgkin's Lymphoma.
Qin Q; Nan X; Miller T; Fisher R; Teh B; Pandita S; Farach AM; Pingali SR; Pandita RK; Butler EB; Pandita TK; Iyer SP
Radiat Res; 2018 Sep; 190(3):322-329. PubMed ID: 29949442
[TBL] [Abstract][Full Text] [Related]
13. Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma.
Navarro-Bailón A; Jiménez C; Alonso-Álvarez S; Alcoceba M; González-Calle V; Chillón MC; García-Álvarez M; Prieto I; Medina A; González M; Caballero MD; Blanco Ó; Díaz LG; García-Sanz R; Sarasquete ME
Hematol Oncol; 2019 Apr; 37(2):215-218. PubMed ID: 30548996
[No Abstract] [Full Text] [Related]
14. The histologic, immunohistochemical, and genetic features of classical Hodgkin lymphoma and anaplastic large cell lymphoma with aberrant T-cell/B-cell antigen expression.
Liang K; Wang J; Wang Y; Zhou Z; Ge S; Mei S; Li H; Jing X; Zhang C
Hum Pathol; 2019 Feb; 84():309-320. PubMed ID: 30339972
[TBL] [Abstract][Full Text] [Related]
15. Checkpoint inhibitors in Hodgkin's lymphoma.
Jezeršek Novaković B
Eur J Haematol; 2016 Apr; 96(4):335-43. PubMed ID: 26560962
[TBL] [Abstract][Full Text] [Related]
16. Interferon-γ Signaling in Melanocytes and Melanoma Cells Regulates Expression of CTLA-4.
Mo X; Zhang H; Preston S; Martin K; Zhou B; Vadalia N; Gamero AM; Soboloff J; Tempera I; Zaidi MR
Cancer Res; 2018 Jan; 78(2):436-450. PubMed ID: 29150430
[TBL] [Abstract][Full Text] [Related]
17. A novel approach to investigation of the pathogenesis of pterygium based on assessment of promoter hyper-methylation and expression profile of CTLA4 gene: A credible report of CTLA4 gene expression in human eye tissue.
Ebrahimi ME; Kordi-Tamandani DM; Arish M
Gene; 2016 Jun; 583(2):130-133. PubMed ID: 26899867
[TBL] [Abstract][Full Text] [Related]
18. In vivo expression of the CTLA4 inhibitory receptor in malignant and reactive cells from human lymphomas.
Xerri L; Devilard E; Hassoun J; Olive D; Birg F
J Pathol; 1997 Oct; 183(2):182-7. PubMed ID: 9390031
[TBL] [Abstract][Full Text] [Related]
19. Checkpoint Inhibitors and Other Immune Therapies for Hodgkin and Non-Hodgkin Lymphoma.
Matsuki E; Younes A
Curr Treat Options Oncol; 2016 Jun; 17(6):31. PubMed ID: 27193488
[TBL] [Abstract][Full Text] [Related]
20. [Expression of natural killer cell development-associated transcription factors in nasal NK/T-cell lymphomas occurring in Chinese population].
Zhang S; Nong L; Zhang Y; Wang Y; Li T
Zhonghua Bing Li Xue Za Zhi; 2010 Jun; 39(6):366-71. PubMed ID: 21055151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
